Accès ouvert
2022
article
OpenAlex
A Gamallo Moure, Sawsen Bekir, Elodie Bacou, Quentin Pruvost et autres
Abstract A bioartificial pancreas (BAP) encapsulating high pancreatic islets concentration is a promising alternative for type 1 diabetes therapy. However, the main limitation of this approach is O 2 supply, especially until graft neovascularization. Here, we described a methodology to design an …
fr, ee
(code pays fourni par la source)
Accès ouvert
2021
preprint
OpenAlex
A Gamallo Moure, Sawsen Bekir, Elodie Bacou, Karine Haurogné et autres
Abstract A bioArtificial pancreas (BAP) encapsulating high pancreatic islets concentration is a promising alternative for type 1 diabetes. However, the main limitation of this approach is O2 supply, especially until graft neovascularization. Here, we described a methodology to design an optimal O2-balanced …
fr
(code pays fourni par la source)
2018
article
OpenAlex
A Gamallo Moure, Elodie Bacou, Steffi Bösch, Dominique Jégou et autres
Abstract The bioartificial pancreas encapsulating pancreatic islets in immunoprotective hydrogel is a promising therapy for Type 1 diabetes. As pancreatic islets are highly metabolically active and exquisitely sensitive to hypoxia, maintaining O2 supply after transplantation remains a major challenge. In this study, …
fr
(code pays fourni par la source)
2017
article
OpenAlex
Apolline Salama, Mathilde Mosser, Xavier Lévêque, Andrea Perota et autres
Xenocell therapy from neonate or adult pig pancreatic islets is one of the most promising alternatives to allograft in type 1 diabetes for addressing organ shortage. In humans, however, natural and elicited antibodies specific for pig xenoantigens, α-(1,3)-galactose (GAL) and N-glycolylneuraminic acid …
fr, it
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
A Fernandez Gato, Francisco Alén, A Gamallo Moure, Gutiérrez López et autres
S1new trend implies a change in the demographic pattern and disease that most commonly affects the elderly.In addition, there has been an increase in certain diseases in old age and a direct relationship of oral disease with systemic diseases of aging own.The …
es
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Isais Peña, Francisco Alén, A Gamallo Moure, M. Peñamaría Mallón et autres
If we compare our results with those of patients younger than 65 years we see that there is a clear difference in effectiveness, being much smaller in the number of older people. Conclusions:1.The use of CO 2 laser is a therapeutic option …
br
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Melanie Villanueva, Francisco Alén, M. Peñamaría Mallón, A Gamallo Moure et autres
Objectives:To analyze the oral topical corticosteroids effects on glycemia levels in diabetic and non-diabetic patients.Material and Methods: Patients older than 65 who were treated with oral topical corticosteroids at the Máster de Medicina oral, Cirugía oral e Implantología and at the Máster …
es
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
M Pena Cristobal, Francisco Alén, A Gamallo Moure, Pilar Gándara Vila et autres
Results: We selected 90 patients, 60 under age 65 and 30 greater of 65 years.We have not found significant clinical difference between the two groups.We have not found differences between findings of epithelial Dysplasia in both groups.The rate of malignant transformation is …
es
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Inés Filipa Rosa Henriques, Francisco Alén, A Gamallo Moure, G Arias Lopez et autres
If we compare our results with those of patients younger than 65 years we see that there is a clear difference in effectiveness, being much smaller in the number of older people. Conclusions:1.The use of CO 2 laser is a therapeutic option …
br
(code pays fourni par la source)